Stock PMCB PHARMACYTE BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart PharmaCyte Biotech, Inc.

Equities

PMCB

US71715X2036

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-31 EDT 		5-day change 1st Jan Change
1.96 USD -2.97% Intraday chart for PharmaCyte Biotech, Inc. -8.41% -9.26%
05-23 MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc. CI
05-20 MyMD Pharmaceuticals, Inc. announced that it expects to receive $14 million in funding from PharmaCyte Biotech, Inc. CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PHARMACYTE BIOTECH, INC. Stock PharmaCyte Biotech, Inc.
 16.57M - - - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
 318B
ABBVIE INC. Stock AbbVie Inc.
 285B
  1. Stock Market
  2. Equities
  3. PMCB Stock
  4. Charts PharmaCyte Biotech, Inc.
  5. Sector Chart